You are here

Home » Content

Diabet ve Akciğer

Diabetes Mellitus and Lung

Journal Name:

  • Uludağ Üniversitesi Tıp Fakültesi Dergisi

Publication Year:

  • 2005

Key Words:

Keywords (Original Language):

Author NameUniversity of Author
Abstract (2. Language): 
Diabetes mellitus is the most prevelant chronic endocrine disease in the community. There is nearly 120 million people with diabetes mellitus worldwide. In our country, the incidence and the prevelance of diabetes mellitus has been reported to be 1,6-2% and 3,5-5 % respectively. Like many complications observed in almost every organ-system, diabetes has some harmful effects on lungs. The most common pulmonary complication observed in diabetic patients is pulmonary infection. In addition to pulmonary infections, diabetes may also cause pulmonary function abnormalities and sleep apne syndrome.
Bookmark/Search this post with
Abstract (Original Language): 
Diabetes Mellitus, toplumda en sık görülen kronik, metabolik hastalıktır. Dünyada yaklaşık 120 milyon diabetli hasta bulunmaktadır. Ülkemizde diabet insidansı %1,6-2, prevelansı ise %3,5-5 olarak bildirilmiştir. Diabetin diğer organ komplikasyonlarının yanı sıra akci- ğerler üzerine de olumsuz etkileri vardır. Diabetli hastalarda en sık görülen pulmoner komplikasyon enfeksiyonlardır. Ayrıca solunum fonksiyonlarında anormallikler ve uyku apne sendromu da görülebilir.
FULL TEXT (PDF): 
PDF icon arastirmax-diabet-akciger.pdf
  • 1
71-74
  • Turkish

REFERENCES

References: 

1. Bennet PH. Classificationand Diagnosis of Diabetes Mellitus.
In: Pickup J, Williams G (eds). Textbook of Diabetes.
London: Blackwell Scientific Publications; 1991. 37-44.
2. Şengöz G. Diabetes mellitus ve enfeksiyon hastalıkları. In:
Yenigün M (ed). Her Yönüyle Diabetes Mellitus. İstanbul:
Nobel Tıp Kitapevi; 2001. 533-43.
3. Nazlıcan Ö, Alan S. Diabetes mellitusta enfeksiyon
immunolojisi. In: Yenigün M (ed). Her Yönüyle Diabetes
Mellitus. İstanbul: Nobel Tıp Kitabevi; 2001. 569-77.
4. Marhoffer W, Stain M, Maeser E, Federlin K. Impairment of
polymorphonuclear leukocyte function and metabolic control
of diabetes. Diabetes Care 1992;15:256-60.
5. Debczynski W, Pietruska Z. Chemotaxis and spontaneus
migration of neutrophil leukocytes from patients with diabetes.
Pol Tyg Lek 1994; 49:11-3.
6. Marfoffer W Stein M, Schleinkofer L, Federlin K. Monitoring
of polymorphonuclear leukocyte functions in diabetes mellitus.
A comparative study of conventional radiometric function
tests and low-light imaging systems. J Biolumin Chemilumin
1994;9:165-70.
7. Delamaire M, Maugendre D, Moreno M, Le Goff MC,
Allannic H, Genetet B. Impaired leucocyte functions in
diabetic patients. Diabet Med 1997;14:29-34.
8. Senior PA, Marshall SM, Thomas TH. Dysregulation of PMN
antigen expression in Type 2 diabetes may reflect a
generalized defect of exocytosis: influence of hypertension
and microalbuminuria. J Leukoc Biol 1999; 65: 800-7.
9. McManus LM, Bloodworth RC, Prihoda TJ, Blodgett JL,
Pinckard RN. Agonist-dependent failure of neutrophil
function in diabetes correlates with extent of hyperglycemia. J
Leukoc Biol 2001;70:395-404.
10. Alfonso C, Han JO, Williams GS, Karlsson L. The impact of
H2-DM on humoral immune responses. J Immunol
2001;167:6348-55. B. B. Erdoğan, ark.
74
11. Michalkova D, Mikulecky M, Tibenska E. Alterations in
lymphocyte subpopulations in peripheral blood at
manifestation of type 1 diabetes mellitus in childhood. Bratisl
Lek Listy 2000; 101: 365-70.
12. Kukreja A, Cost G Marker J, Zhang C, Sun Z, Lin-Su K, Ten
S, et all. Multiple immuno-regulatory defects in type-1
diabetes. J Clin Invest 2002;109:131-40.
13. Matthay MA. The Lungs and Endocrine Disease. In: Murray
JF, Nadel JA. Textbook of Respiratory Medicine.
Philadelphia: W.B. Saunders Company; 1994;2463-74.
14. Koziel H, Koziel MJ. Pulmonary complications of diabetes
mellitus. Pneumonia. Infect Dis Clin North Am 1995;9:65-96.
15. Erişkin ve Çocuklarda Toplum Kökenli Pnömoniler ve Akut
Bronşiolit Tanı Ve Tedavi Rehberi. Toraks Dergisi Cilt 3, Ek
3, 2002.
16. Wang Ch, Yu CT, Lin HC, Liu CY, Kuo HP. Hypodense
alveolar macrophages in patients with diabetes mellitus and
active pulmonary tuberculosis. Tuber Lung Dis 1999; 79: 235-
42.
17. Bacakoglu F, Basoglu OK, Cok G, Sayiner A, Ates M.
Pulmonary tuberculosis in patients with diabetes mellitus.
Respiration 2001; 68: 595-600.
18. Morris JT, Seaworth BJ, McAllister CK. Pulmonary
tuberculosis in diabetics. Chest 1992;102:539-41.
19. Bashar M, Alcabes P, Rom WN, Condos R. Increased
incidence of multidrug-resistant tuberculosis in diabetic
patients on the Bellevue Chest Service, 1987 to 1997. Chest
2001;120:1435-7.
20. Nicolaie T, Zavoianu C, Nuta P. Pulmonary involvement in
diabetes mellitus. Rom J Intern Med. 2003;41:365-74.
21. Hsia CC, Raskin P. The diabetic lung: relevance of alveolar
microangiopathy for the use of inhaled insulin. Am J Med
2005;118:205-11.
22. Dalquen P. The lung in diabetes mellitus. Respiration
1999;66:12-3.
23. Weynand B, Jonckheere A, Frans A, Rahier J. Diabetes
mellitus induces a thickening of the pulmonary basal lamina.
Respiration 1999; 66: 14-9.
24. Scano G, Filippelli M, Romagnoli I, Mancini M, Misuri G,
Duranti R, Rosi E. Hypoxic and hypercapnic breathlessness in
patients with type 1 diabetes mellitus. Chest 2000;117:960-7.
25. Mancini M, Filippelli M, Seghieri G, Iandelli I, Innocenti F,
Duranti R,Scano G. Respiratory muscle function and hypoxic
ventilatory control in patients with type 1 diabetes. Chest
1999;115:1553-62.
26. Ljubic S, Metelko Z, Car N, Roglic G, Drazic Z. Reduction of
diffusion capacity for carbon monoxide in diabetic patients.
Chest 1998;114:1033-5.
27. Cazzato S, Bernardi F, Salardi S, Tassinari D, Corsini I, Ragni
L, Cicognani A, Cacciari E. Lung function in children with
diabetes mellitus. Pediatr Pulmonol 2004; 37:17-23.
28. Boulbou MS, Gourgoulianis KI, Klisiaris VK, Tsikrikas TS,
Stathakis NE, Molyvdas PA. Diabetes mellitus and lung
function. Med Princ Pract 2003;12:87-91.
29. Bottini P, Scionti L, Santeusanio F, Casucci G, Tantucci C.
Impairment of the respiratory system in diabetic autonomic
neuropathy. Diabetes Nutr Metab 2000;13:165-72.
30. Cavalher-Machado SC, de Lima WT, Damazo AS, de Frias
Carvalho V, Martins MA, e Silva PM, Sannomiya P. Downregulation of mast cell activation and airway reactivity in
diabetic rats: role of insulin. Eur Respir J 2004;24:552-8.
31. Bottini P, Tantucci C. Sleep apnea syndrome in endocrine
diseases. Respiration. 2003; 70:320-7
32. Royle P, Waugh N, McAuley L, McIntyre L, Thomas S.
Inhaled insulin in diabetes mellitus. Cochrane Database Syst
Rev 2004;3:CD003890.

Thank you for copying data from http://www.arastirmax.com